Study details
Enrolling now
Ferric Citrate and Chronic Kidney Disease in Children
University of California, Los Angeles
NCT IDNCT04741646ClinicalTrials.gov data as of Apr 2026
Phase
Phase 2
Target enrollment
160
Study length
about 5.4 years
Ages
6–18
Locations
18 sites in CA, FL, GA +8
About this study
Researchers are testing whether ferric citrate (FC) can help change levels of a substance called intact FGF23 in children with chronic kidney disease. The trial will last 1962 days and involve about 160 children aged 6-18 years old, randomly assigned to either receive FC or a placebo.
Based on ClinicalTrials.gov records.
What participants do
- 1.Take Ferric Citrate
- 2.Take Placebo
PhasePhase 2
DrugFerric Citrate
Routeoral
Primary goalTolerability of Ferric Citrate
Participation effort
Estimated from trial records. Details can vary by site.
Time + visits
Low11%
Logistics
Moderate50%
Logistics difficulty varies by site location and availability.
Trial highlights
Treatment details
Auto-extracted from trial records to preview treatments and outcomes.
Drug classes
ferric citrate
Drug routes
oral (Oral Tablet)
Endpoints
Primary: Tolerability of Ferric Citrate
Body systems
Renal